Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 121 - 130 of 206

Selected Filters:
6 February 2023

Pregnancy and Neonatal Safety Outcomes of Timing of Initiation of Daily Oral Tenofovir Disoproxil Fumarate and Emtricitabine Pre-exposure Prophylaxis for HIV Prevention (CAP016): An open-label, randomised, non-inferiority trial

This article from The Lancet HIV describes the results of a trial to compare pregnancy and neonatal outcomes in women exposed and not exposed to oral PrEP (TDF/FTC) during pregnancy in Durban, South Africa.

Research

External Link
1 February 2023

Discontinuation of Government Subsidized HIV Pre-exposure Prophylaxis in Australia: A whole-of-population analysis of dispensing records

This article from the Journal of the International AIDS Society examines the impact of discontinuation on overall PrEP usage, the proportion of PrEP users who discontinue and the predictors of discontinuation in Australia.

Monitoring & Evaluation, Research

External Link
30 January 2023

HIV Pre-exposure Prophylaxis (PrEP) Knowledge among General Practitioners in 2020: A French survey

This article from Infectious Diseases Now analyses the knowledge of and position on PrEP amongst general practitioners in Hauts-de-France, France.

Service Delivery

External Link
30 January 2023

An Update on Expanding HIV Preexposure Prophylaxis

This article from the Journal of the American Academy of Physicians Assistants describes how to better employ PrEP in the United States in light of changes to the Centers for Disease Control guidelines on PrEP counselling, monitoring, and delivery, and approval of injectable cabotegravir for PrEP by the US Food and Drug Administration.

Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

External Link
30 January 2023

Same-day Initiation of Oral Pre-exposure Prophylaxis among Gay, Bisexual, and Other Cisgender Men who Have Sex with Men and Transgender Women in Brazil, Mexico, and Peru (ImPrEP): A prospective, single-arm, open-label, multicentre implementation study

This article from The Lancet HIV assesses the feasibility of same-day oral PrEP delivery amongst gay and bisexual men who have sex with men and transgender women in Brazil, Mexico, and Peru.

Service Delivery

External Link
23 January 2023

Cost-effectiveness Analysis of the Daily HIV Pre-exposure Prophylaxis in Men who Have Sex with Men in Barcelona

This article from PLOS One models the cost-effectiveness of daily oral PrEP use amongst gay and bisexual men who have sex with men in Barcelona, Spain.

Financing & Costing, Research

External Link
23 January 2023

Estimating the Impact of HIV PrEP Regimens Containing Long-acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine among Men who Have Sex with Men in the United States: A mathematical modelling study for HPTN 083

This article from The Lancet Regional Health- Americas describes the results of a modelling exercise which compares the potential population-level impact of oral PrEP (TDF/FTC) and Cabotegravir for PrEP among gay and bisexual men who have sex with men in Atlanta, Georgia, USA.

Research

External Link
23 January 2023

Nurse-facilitated PrEP Delivery for Adolescent Girls and Young Women Seeking Contraception at Retail Pharmacies in Kisumu, Kenya

This article from AIDS evaluates PrEP uptake, initiation, and continuation within a nurse-facilitated pharmacy-based delivery model for Kenyan adolescent girls and young women seeking contraception at retail pharmacies.

Research, Service Delivery

External Link
23 January 2023

Efficacy of Daily Text Messaging to Support Adherence to HIV Pre-Exposure Prophylaxis (PrEP) among Stimulant-Using Men Who Have Sex with Men

This article from Substance Use & Misuse evaluates the efficacy of the individualized Texting for Adherence Building (iTAB) intervention for PrEP adherence among 119 gay and bisexual men who have sex with men who use stimulants in California, USA.

Research, Service Delivery

External Link
16 January 2023

Primary Care Provider HIV PrEP Knowledge, Attitudes, and Prescribing Habits: A cross-sectional survey of late adopters in rural and suburban practice

This article from the Journal of Primary Care & Community Health describes the current knowledge, attitudes, and prescribing behaviors of HIV PrEP in primary care providers in Pennsylvania, USA with a focus on the perceived barriers and facilitators to PrEP prescribing.

Research, Service Delivery

External Link